Chirurgovia sa stretli na Viedenskom sympóziu, aby si vyskúšali tesniace hemostatikum HEMOPATCH značky Baxter DEERFIELD, Illinois, 18. august 2025 /PRNewswire/ – Dôveryhodnosť už viac ako desaťročie. Už viac ako desať rokov je tesniace hemostatikum Hemopatch...
Monday, August 18, 2025 BiopharmaWatch Research 1 min read
Key Takeaway: Baxter's Hemopatch has been a reliable hemostatic aid for over ten years, providing essential support during surgeries worldwide. The product is noted for its precision under pressure and continues to evolve with healthcare settings. Its longstanding trustworthiness highlights its importance in surgical procedures.
Price reaction · baseline $24.18 (2025-08-15 close) · clean, no other BAX news in the window
day 0 close · peak
-2.4%
Market Sentiment Analysis
POSITIVE FACTORS
Hemopatch has been a trusted hemostatic aid for over a decade.
It provides critical support and precision under pressure.
The product is evolving alongside healthcare environments.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+18%
120-day peak, hindsight
Typical move
1.9%
average across 12 past catalysts
Lead asset
Dianeal
Phase 3 · End Stage Renal Disease (ESRD)
Full Press Release Details
DEERFIELD, Illinois , 18. august 2025 /PRNewswire/ –
Dôveryhodnosť už viac ako desaťročie. Už viac ako desať rokov je tesniace hemostatikum Hemopatch dôveryhodnou pomôckou pri operáciách po celom svete, poskytuje kritickú oporu a presnosť pod tlakom a zároveň sa spolu so zdravotníckym prostredím vyvíja.
Frequently Asked Questions
What is Hemopatch?
Hemopatch is a hemostatic aid developed by Baxter, trusted for over a decade.
How long has Hemopatch been in use?
Hemopatch has been a reliable surgical aid for more than ten years.
What are the benefits of Hemopatch?
It provides critical support and precision under pressure during surgeries.
How does Hemopatch evolve?
Hemopatch evolves alongside healthcare environments to meet surgical needs.